We synthesized three novel lipophilic derivatives of phenylalanyl-glycine (Phe-Gly), C4-Phe-Gly, C6-Phe-Gly and C8-Phe-Gly by chemical modification with butyric acid (C4), caproic acid (C6) and octanoic acid (C8). The effect of the acylation on the stability, permeability and accumulation of Phe-Gly in the skin was investigated by in vitro studies. The stability of Phe-Gly in skin homogenates was low, but was significantly improved by the acylation. In the transport studies, a Franz-type diffusion cell was used for the permeability experiments with Phe-Gly and its acyl derivatives. The permeability of acyl-Phe-Gly derivatives across the intact skin was higher than that of native Phe-Gly. Of all the acyl-Phe-Gly derivatives, C6-Phe-Gly was the most permeable compounds across the intact skin. On the other hand, the permeability of acyl-Phe-Gly derivatives across stripped skin was less than that of native Phe-Gly in the initial time period of transport studies, but their permeability was higher than that of native Phe-Gly at the end of the transport studies. When the skin was pretreated with ethanol, which could inactivate the peptidases responsible for the degradation of Phe-Gly, the permeability of native Phe-Gly was higher than that of acyl derivatives. These findings indicated the involvement of peptidases on the permeability of Phe-Gly across the skin. The relationship between the lipophilic indexes of Phe-Gly derivatives and the permeability coefficients indicated that there is an optimal carbon number of fatty acid for improving the transdermal permeability of Phe-Gly by the acylation. A good correlation was found between the accumulation of these acyl-Phe-Gly derivatives in the intact skin and their lipophilicity. These results suggest that the stability and permeability of Phe-Gly were improved by chemical modification with fatty acids and this enhanced permeability of Phe-Gly by the acylation may be attributed to the protection of Phe-Gly from the enzymatic degradation in the skin and the increase in the partition of Phe-Gly to the stratum corneum.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-5173(02)00536-7DOI Listing

Publication Analysis

Top Keywords

phe-gly
16
acyl-phe-gly derivatives
16
native phe-gly
16
permeability phe-gly
16
chemical modification
12
phe-gly skin
12
transport studies
12
intact skin
12
permeability
11
skin
9

Similar Publications

Unlabelled: Lenacapavir (LEN) is the first in class viral capsid protein (CA) targeting antiretroviral for treating multi-drug-resistant HIV-1 infection. Clinical trials and cell culture experiments have identified resistance associated mutations (RAMs) in the vicinity of the hydrophobic CA pocket targeted by LEN. The M66I substitution conferred by far the highest level of resistance to the inhibitor compared to other RAMs.

View Article and Find Full Text PDF
Article Synopsis
  • * USFDA-approved drugs that block VEGFR2 face issues like drug resistance and heart-related side effects, highlighting the need for safer and more effective treatments.
  • * The review discusses recent findings on the structure and function of VEGFR2 inhibitors, including crucial molecular interactions and design requirements for developing new cancer therapies.
View Article and Find Full Text PDF

Recently, the fungus secondary metabolite cyclotetrapetide c[Trp-Phe-D-Pro-Phe] (CJ-15,208) and its derivatives deserved some attention for their unusual structure and distinctive in vitro and in vivo activity. These tryptophan-containing noncationic opioid peptides can be truly regarded as versatile picklocks capable of activating all opioid receptors. Intriguingly, minimal modification of the potent κ-opioid receptor (KOR) agonist c[D-Trp-Phe-Gly-β-Ala] () yielded c[D-Trp-Phe-β-Ala-β-Ala] (), the first KOR-specific negative allosteric modulator (NAM) reported to-date.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the relationship between gut microbiome and metabolites in pregnant women with gestational diabetes mellitus (GDM) compared to those without, highlighting the role of gut microbial metabolites in diabetes.
  • - Key findings show that phenylalanine and nucleotide metabolism pathways are notably different between the two groups, with specific metabolites like Phenylalanylglycine and uracil being significantly altered in GDM patients.
  • - An increase in the gut symbiont Clostridium, part of the Firmicutes class, was linked to disruptions in phenylalanine metabolism in GDM, suggesting a potential therapeutic target for managing the condition.
View Article and Find Full Text PDF

Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates.

J Control Release

November 2024

University of Padova, Dept. Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padova, Italy. Electronic address:

In this work, we conceived and developed antibody-drug conjugates (ADCs) that could efficiently release the drug after enzymatic cleavage of the linker moiety by tumoral proteases. The antibody-drug linkers we used are the result of a rational optimization of a previously reported PEGylated linker, PUREBRIGHT® MA-P12-PS, which showed excellent drug loading capacities but lacked an inbuilt drug discharge mechanism, thus limiting the potency of the resulting ADCs. To address this limitation, we chose to incorporate a protease-sensitive trigger into the linker to favor the release of a "PEGless" drug inside the tumor cells and, therefore, obtain potent ADCs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!